NASDAQ:CYTK
Cytokinetics Stock News
$64.02
-1.25 (-1.92%)
At Close: May 09, 2024
Cytokinetics Trading at Half High Target of $30
09:59pm, Monday, 04'th May 2020
Biopharma’s shares up 40% year to date. It reports 1st-quarter results May 6 Continue reading...
Is Cytokinetics, Incorporated (NASDAQ:CYTK) Excessively Paying Its CEO?
11:58am, Monday, 04'th May 2020
Robert Blum has been the CEO of Cytokinetics, Incorporated (NASDAQ:CYTK) since 2007. This analysis aims first to...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Wendall Wierenga Sells 9,999 Shares of Cytokinetics, Inc. (NASDAQ:CYTK) Stock
09:30am, Saturday, 02'nd May 2020
Cytokinetics, Inc. (NASDAQ:CYTK) Director Wendall Wierenga sold 9,999 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $16.00, for a t
Edited Transcript of AMGN earnings conference call or presentation 30-Apr-20 9:30pm GMT
10:54am, Friday, 01'st May 2020
Q1 2020 Amgen Inc Earnings Call
Bank of America Corp DE Lowers Stock Position in Cytokinetics, Inc. (NASDAQ:CYTK)
09:17am, Friday, 01'st May 2020
Bank of America Corp DE lessened its holdings in Cytokinetics, Inc. (NASDAQ:CYTK) by 22.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 32,487 shares of the bio
Cytokinetics (NASDAQ:CYTK) Shares Down 7.2% on Insider Selling
06:58am, Friday, 01'st May 2020
Cytokinetics, Inc. (NASDAQ:CYTK)’s share price traded down 7.2% during trading on Thursday following insider selling activity. The company traded as low as $14.88 and last traded at $15.11, 562,407
Amgen Inc (NASDAQ: AMGN) Q1 2020 Earnings Call Transcript | AlphaStreet
05:05am, Friday, 01'st May 2020
Final earnings conference call transcript of Amgen Inc - AMGN stock
3 Monster Growth Stocks That Are Still Undervalued
12:33pm, Thursday, 30'th Apr 2020
The market is on the move, and this time stocks took off on an upward trajectory. On Wednesday April 29, all three of the major U.S. stock indexes posted gains at the closing bell, climbing higher on
3 Monster Growth Stocks That Are Still Undervalued
12:31pm, Thursday, 30'th Apr 2020
The market is on the move, and this time stocks took off on an upward trajectory. On Wednesday April 29, all three of the major U.S. stock indexes posted
A Director at Cytokinetics is Exercising Options
12:06am, Thursday, 30'th Apr 2020
Yesterday it was reported that a Director at Cytokinetics (CYTK), Wendall Wierenga, exercised options to sell 9,999 CYTK shares at $10.24 a share, for a
A Director at Cytokinetics is Exercising Options
12:06am, Thursday, 30'th Apr 2020
Yesterday it was reported that a Director at Cytokinetics (CYTK – Research Report), Wendall Wierenga, exercised options to sell 9,999
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:34pm, Wednesday, 29'th Apr 2020
Cytokinetics (CYTK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:34pm, Wednesday, 29'th Apr 2020
Cytokinetics (CYTK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
